• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5081245)   Today's Articles (85)
For: Shimatani K, Yoshimoto T, Doi Y, Sonoda T, Yamamoto S, Kanematsu A. Two cases of nonbacterial cystitis associated with nivolumab, the anti-programmed-death-receptor-1 inhibitor. Urol Case Rep 2018. [PMID: 29541592 PMCID: PMC5849865 DOI: 10.1016/j.eucr.2017.12.006] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]  Open
Number Cited by Other Article(s)
1
Alhusari L, Abdallah M, Nwanwene K, Shenouda M. Acute Non-infectious Cystitis Secondary to Immune-Related Adverse Events in a Patient Receiving Pembrolizumab for Treatment of Non-small Cell Lung Cancer: A Case Report. Cureus 2024;16:e55666. [PMID: 38586668 PMCID: PMC10997305 DOI: 10.7759/cureus.55666] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/06/2024] [Indexed: 04/09/2024]  Open
2
Fan Y, Zhao J, Mi Y, Zhang Z, Geng Y, Zhou L, Shen L, Zhang Z. Recurrent Cystitis Associated With 2 Programmed Death 1 Inhibitors: A Rare Case Report and Literature Review. J Immunother 2023;46:341-345. [PMID: 37721343 PMCID: PMC10540753 DOI: 10.1097/cji.0000000000000484] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2022] [Accepted: 08/16/2023] [Indexed: 09/19/2023]
3
Zhou Q, Qin Z, Yan P, Wang Q, Qu J, Chen Y. Immune-related adverse events with severe pain and ureteral expansion as the main manifestations: a case report of tislelizumab-induced ureteritis/cystitis and review of the literature. Front Immunol 2023;14:1226993. [PMID: 37869004 PMCID: PMC10587548 DOI: 10.3389/fimmu.2023.1226993] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2023] [Accepted: 09/25/2023] [Indexed: 10/24/2023]  Open
4
LI S, ZHENG K, XU Y, WANG M. [Immune Checkpoint Inhibitors Related Cystoureteritis:
A Case Report and Literature Review]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2023;26:709-716. [PMID: 37985157 PMCID: PMC10600747 DOI: 10.3779/j.issn.1009-3419.2023.106.17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 04/13/2023] [Indexed: 11/22/2023]
5
Anraku T, Hashidate H, Imai T, Kawakami Y. Successful treatment of immune‐related cystitis with bladder hydrodistension. IJU Case Rep 2023. [DOI: 10.1002/iju5.12588] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/07/2023]  Open
6
Li J, Yu YF, Qi XW, Du Y, Li CQ. Immune-related ureteritis and cystitis induced by immune checkpoint inhibitors: Case report and literature review. Front Immunol 2023;13:1051577. [PMID: 36685488 PMCID: PMC9853439 DOI: 10.3389/fimmu.2022.1051577] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2022] [Accepted: 12/05/2022] [Indexed: 01/07/2023]  Open
7
Hu Y, Lu W, Tang B, Zhao Z, An Z. Urinary incontinence as a possible signal of neuromuscular toxicity during immune checkpoint inhibitor treatment: Case report and retrospective pharmacovigilance study. Front Oncol 2022;12:954468. [PMID: 36172143 PMCID: PMC9510979 DOI: 10.3389/fonc.2022.954468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2022] [Accepted: 08/12/2022] [Indexed: 11/21/2022]  Open
8
Non-bacterial cystitis secondary to pembrolizumab: A case report and review of the literature. Curr Probl Cancer 2022;46:100863. [DOI: 10.1016/j.currproblcancer.2022.100863] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2021] [Revised: 02/10/2022] [Accepted: 04/07/2022] [Indexed: 11/19/2022]
9
Obayashi A, Hamada-Nishimoto M, Fujimoto Y, Yoshimoto Y, Takahara S. Non-bacterial Cystitis With Increased Expression of Programmed Cell Death Ligand 1 in the Urothelium: An Unusual Immune-Related Adverse Event After Atezolizumab Administration for Metastatic Breast Cancer. Cureus 2022;14:e25486. [PMID: 35800819 PMCID: PMC9246443 DOI: 10.7759/cureus.25486] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/26/2022] [Indexed: 11/05/2022]  Open
10
Wang Z, Zhu L, Huang Y, Peng L. Successful Treatment of Immune-related Cystitis by Chai-Ling-Tang (Sairei-To) in a Gastric Carcinoma Patient: Case Report and Literature Review. Explore (NY) 2022;19:458-462. [PMID: 35469747 DOI: 10.1016/j.explore.2022.04.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2022] [Accepted: 04/02/2022] [Indexed: 12/16/2022]
11
Zhu S, Bian L, Lv J, Liu B, Shen J. A Case Report of Non-Bacterial Cystitis Caused by Immune Checkpoint Inhibitors. Front Immunol 2022;12:788629. [PMID: 35003107 PMCID: PMC8733335 DOI: 10.3389/fimmu.2021.788629] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2021] [Accepted: 12/06/2021] [Indexed: 12/19/2022]  Open
12
Murray T, Haagsma B, Chetwood A. Non-infective cystitis secondary to benralizumab immunotherapy. BMJ Case Rep 2022;15:e244733. [PMID: 35039341 PMCID: PMC8768471 DOI: 10.1136/bcr-2021-244733] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/04/2021] [Indexed: 11/04/2022]  Open
13
Tu L, Ye Y, Tang X, Liang Z, You Q, Zhou J, Pan Z. Case Report: A Case of Sintilimab-Induced Cystitis/Ureteritis and Review of Sintilimab-Related Adverse Events. Front Oncol 2022;11:757069. [PMID: 35004277 PMCID: PMC8733470 DOI: 10.3389/fonc.2021.757069] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2021] [Accepted: 12/06/2021] [Indexed: 01/26/2023]  Open
14
El Husseini K, Lafoeste H, Mansuet-Lupo A, Arrondeau J, Villeminey C, Bennani S, Revel MP, Wislez M. A case of severe interstitial cystitis associated with pembrolizumab. CURRENT PROBLEMS IN CANCER: CASE REPORTS 2021. [DOI: 10.1016/j.cpccr.2021.100101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]  Open
15
Schneider S, Alezra E, Yacoub M, Ducharme O, Gerard E, Dutriaux C, Prey S. Aseptic cystitis induced by nivolumab and ipilimumab combination for metastatic melanoma. Melanoma Res 2021;31:487-489. [PMID: 34433197 DOI: 10.1097/cmr.0000000000000765] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
16
Zhu L, Wang Z, Stebbing J, Wang Z, Peng L. Immunotherapy-Related Cystitis: Case Report and Review of the Literature. Onco Targets Ther 2021;14:4321-4328. [PMID: 34366676 PMCID: PMC8336986 DOI: 10.2147/ott.s321965] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2021] [Accepted: 07/19/2021] [Indexed: 12/20/2022]  Open
17
Yajima S, Nakanishi Y, Matsumoto S, Tanabe K, Sugano M, Masuda H. Improvement of urinary symptoms after bladder biopsy: A case of pathologically proven allergy-related cystitis during administration of nivolumab. IJU Case Rep 2021;4:213-215. [PMID: 34308272 PMCID: PMC8294138 DOI: 10.1002/iju5.12286] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2021] [Accepted: 03/10/2021] [Indexed: 11/11/2022]  Open
18
Dowell AC, Munford H, Goel A, Gordon NS, James ND, Cheng KK, Zeegers MP, Ward DG, Bryan RT. PD-L2 Is Constitutively Expressed in Normal and Malignant Urothelium. Front Oncol 2021;11:626748. [PMID: 33718196 PMCID: PMC7951139 DOI: 10.3389/fonc.2021.626748] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2020] [Accepted: 01/15/2021] [Indexed: 11/14/2022]  Open
19
Ueki Y, Matsuki M, Kubo T, Morita R, Hirohashi Y, Sato S, Horibe R, Matsuo K, Tsukahara T, Kanaseki T, Takakuwa Y, Satoh M, Itoh N, Torigoe T. Non-bacterial cystitis with increased expression of programmed death-ligand 1 in the urothelium: An unusual immune-related adverse event during treatment with pembrolizumab for lung adenocarcinoma. IJU Case Rep 2020;3:266-269. [PMID: 33163921 PMCID: PMC7609190 DOI: 10.1002/iju5.12211] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2020] [Revised: 06/23/2020] [Accepted: 07/22/2020] [Indexed: 11/15/2022]  Open
20
Okazaki T, Okazaki IM. Stimulatory and Inhibitory Co-signals in Autoimmunity. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2019;1189:213-232. [PMID: 31758536 DOI: 10.1007/978-981-32-9717-3_8] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA